Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a -78.784\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a Cc1ccc2cc(CN(C)C(=O)C3CCCO3)c(=O)[nH]c2c1
b O=C(Nc1ccc([N+](=O)[O-])cc1)N1CCc2ccccc2C1
c COc1ccccc1C(=O)Nc1ccc2c(c1)nc(CCNC(=O)c1ccco1)n2C
d Cc1nccn1CCCN1C(=O)/C(=C/c2ccc(C#N)cc2)NC1=S
e O=C(Nc1ccccc1)N1CCN(S(=O)(=O)c2ccccc2)CC1
Answer: d. Cc1nccn1CCCN1C(=O)/C(=C/c2ccc(C#N)cc2)NC1=S
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nccn1CCCN1C(=O)/C(=C/c2ccc(C#N)cc2)NC1=S
Cc1nccn1CCCN1C(=O)/C(=C/c2ccc(C#N)cc2)NC1=S
4-[(Z)-[1-[3-(2-methylimidazol-1-yl)propyl]-5-oxo-2-sulfanylideneimidazolidin-4-ylidene]methyl]benzonitrile